When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BELLUS Health (BLU) has filed to raise gross proceeds of $60 million from a U.S. IPO, according to an F-10 registration statement.
The firm is developing therapeutics for chronic cough and other hypersensitization disorders.
BLU is in the middle of Phase 2 trials for its lead program but there is no existing investor support for the IPO.
Company & Technology
Laval, Canada-based BELLUS was founded in 2010 to focus on developing therapeutics for chronic cough and other chronic pruritus conditions associated with atopic dermatitis.